Agoracom Blog Home

Archive for the ‘Enertopia’ Category

Medical pot cookie prohibition ruled unconstitutional

Posted by AGORACOM-JC at 10:31 AM on Friday, August 15th, 2014

Court challenge stems from B.C. case of Owen Smith, who was charged with trafficking for baking pot cookies

CBC News Posted: Aug 14, 2014 10:42 AM PT Last Updated: Aug 15, 2014 6:35 AM PT

Ban on medical marijuana cookies ruled unconstitutional 1:57

It’s unconstitutional to forbid licensed medical marijuana users from possessing pot-laced products, such as cookies or body creams, a B.C. Court of Appeal judge has ruled.

Parliament has been given one year to recraft regulations to allow medicinal marijuana users to use products made from cannabis extract. They can include creams, salves, oils, brownies, cakes, cookies and chocolate bars.

Health Canada currently allows people suffering from debilitating illnesses access to medicinal marijuana, but only in the form of dried marijuana.

In her written reasons, Justice Risa Levine said this specification “is arbitrary and cannot be justified in a free and democratic society.”

Levine went on to state that when patients choose to use edible forms of marijuana, it “was a matter of necessity, or put another way, the restriction to dried marijuana interfered with their physical or psychological integrity.”

Pot activists react to ruling RAW2:25

Case of the pot cookie baker

The court challenge stems from the case of Owen Smith, who was charged with trafficking for baking pot cookies and producing topical cannabis creams for a medical marijuana club in Victoria in 2009.

Smith was caught baking more than 200 pot cookies for the Victoria Cannabis Buyers Club, and had a supply of cannabis-infused cooking oils and some dried dope in his apartment when he was arrested.

Marijuana ruling - Owen Smith pot cookie bakerOwen Smith was caught baking more than 200 pot cookies for the Victoria Cannabis Buyers Club in 2009. (CHEK)

He was acquitted in April 2012 after the B.C. Supreme Court ruled the medical marijuana regulations were unconstitutional, because patients were denied access to edible pot products and derivatives.

Justice Robert Johnston concluded that permitting dried cannabis alone was arbitrary and did little to further a legitimate state interest.

Thursday’s ruling means Smith acquittal stands and he will not be retried.

Health Minister Rona Ambrose’s office said in a statement released Thursday that it is “reviewing the decision in detail and considering our options.”

Marijuana laws under the microscope

Canada currently prohibits the possession and trafficking of all marijuana products under subsection 4(1) and Schedule II of the Controlled Drugs and Substances Act. However, subsection 55(1) of this act allows for exemptions to be made.

As such, an annex to that act, the Marihuana for Medical Purposes Regulations, allow people with medical need and authorization access to medicinal marijuana.

Under these regulations, many people suffering from debilitating illnesses get marijuana through Health Canada approved companies or get permission to grow it themselves.

However, the MMPR and its predecessor, the MMAR program, limit this access to dried marijuana and do not make any other exceptions to the list of banned substances detailed in Schedule II of the Controlled Drugs and Substances Act.

These banned substances, aside from the exempted dried marijuana, include cannabis resin and various extracts and derivatives of the cannabis plant.

Ottawa had hoped the B.C. Court of Appeal would strike down the B.C. Supreme Court decision.

But under Thursday’s ruling, government has been asked to review these rules, which could mean medical marijuana users would be supplied with resin or extract or be permitted to make themselves products such as pot cookies using marijuana extracts.

RULING | Full B.C. Court of Appeal ruling on medical marijuana extract case

Source: http://www.cbc.ca/news/canada/british-columbia/medical-pot-cookie-prohibition-ruled-unconstitutional-1.2736526

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Enertopia Provides Corporate Update

Posted by AGORACOM-JC at 8:07 AM on Tuesday, August 5th, 2014

VANCOUVER, BC /August 5, 2014 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) announces the following corporate update.

With the recent success of the Burlington municipal approval the Company is pleased to announce it has issued 118,416 shares to 1475714 Ontario Inc. as required under the building lease agreement for its base share of lease costs for the remainder of 2014 under the Lease agreement. The Company and its JV partner Lexaria Corp will have a project update in the coming weeks.

The Company is currently reviewing opportunities in the oil & edibles, and industrial hemp markets across North America, as it looks to broaden its opportunities for multiple streams of revenue.

The Company has also engaged Neil Blake to help out with our Investors Relations outreach.

The Enertopia website has been updated to reflect the company’s growing focus on patient well being as the investment community grows in its understanding of the importance of Medical marijuana and the importance of natural CBD medication, please visit www.enertopia.com

Follow Enertopia:

Twitter: www.twitter.com/EnertopiaCorp

Facebook: www.Facebook.com/EnertopiaCorp

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that the Burlington JV will obtain a license under MMPR and or that the Company will be able to obtain future financings. Similarly, there can be no assurance that the Company will be successful in securing operations in the oils, edibles or hemp markets.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Parents of six-year-old medical marijuana user calling for legal access to marijuana oil

Posted by AGORACOM-JC at 10:11 AM on Tuesday, July 29th, 2014

CTV Ottawa

The parents of six-year-old Ottawa Constance Bay boy who suffers from a rare form of epilepsy are desperately calling for changes to Canada’s medicinal marijuana laws.

Liam McKnight’s parents are breaking the rule by giving him marijuana oil to help treat his severe seizures.

Liam has Dravet Syndrome, a rare form of epilepsy that causes him to suffer violent seizures, sometimes dozens a day.

But under Heath Canada rules, licensed producers can only produce and distribute dried marijuana.

Liam’s mother Mandy McKnight says her son is technically only allowed to smoke it or vaporize it.

But she doesn’t want Liam smoking marijuana, and she says he wouldn’t be able to anyway.

Liam is developmentally delayed, and his mother says he would not understand how to inhale it.

McKnight says the best way for Liam to receive the medical benifits of the drug is to ingest it as an oil, not to smoke it.

The strain of marijuana Liam is taking is higher in CBD, the compound that helps him, and very low in THC, the compound that produces the drug’s “high” effects.

Liam’s mom says they have tried several different medications to treat Liam’s seizures, and so far marijuana oil has been their best defence against them.

Liam’s parents are calling on the federal government to make medicinal marijuana oil legal.

Right now, they must go through the costly and lengthy process of buying the dried marijuana, having it converted into oil, then tested to check its properties so they can determine the proper dosage to give Liam.

They say they don’t know how long they can sustain that.

According to Health Canada, “current regulations for clinical trials would allow a sponsor to propose a clinical trial for extracts of cannabis. A manufacturer or another sponsor (e.g., a physician or treatment centre) can submit a clinical trial application to Health Canada at any time.”

But the McNights say they don’t have time to wait for a clinical trial.

They say last year, 14 children in their Dravet Syndrome support group passed away.

They want Liam to have easier access to the oil so his quality of life can be improved.
“I don’t understand why Health Canada is preventing him from accessing a medication that could potentially save his life, or extend it for a very long period of time,” Mandy McKnight said.

“We’re trying to do everything we can to just give him a break, and give him a chance to just be a kid,” she said. “I think it’s a viable treatment option, and he deserves a chance to try it.”

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

A Closer Look at Enertopia’s Three MMJ Projects

Posted by AGORACOM-JC at 10:00 AM on Monday, June 23rd, 2014

WHITEFISH, MT / June 23, 2014 / Canada’s Marijuana for Medical Purposes Regulations (“MMPR”) has attracted a lot of investor interest, as evidenced by Tweed Marijuana Inc.’s (TSX-V: TWD) (OTC: TWMJF) nearly $100 million market capitalization. Health Canada estimates that the market for legalized marijuana could surpass $1.3 billion with 450,000 patients over the next ten years, while adult use legalization could eventually add to the total.

With only 13 licensed producers under the MMPR program, investors have the choice of either investing in a handful of approved licensed producers, like Tweed, or investing in companies pursuing a license. Those pursuing a license could offer greater upside given Tweed’s $100 million plus valuation, with some companies pursuing licenses trading in the sub-$15 million price range.

Enertopia Corp. (OTC: ENRT) (CSE: TOP) is one of the companies pursuing a license with three separate projects in its pipeline. With its diverse exposure, the company’s experienced management team aims to increase its odds of success in obtaining an MMPR license. The three projects also have a combined capacity of about 64,000 net square feet of production space, which would make it among the larger producers.

Also See: Enertopia Corp.’s Exclusive Interview with CannabisFN

Green Canvas Facility

In February 2014, Enertopia announced a joint venture whereby it acquired 75% of Green Canvas for C$1 million and 19 million shares over a three-year period. The Saskatchewan-based facility will have an initial build-out of 14,000 square feet of grow space, which could eventually be scaled to 55,000 square feet.

The Green Canvas Facility is currently a producer under the existing MMAR program, which should help the application for their MMPR license to be approved. The facility has recently undergone security upgrades and is awaiting further review from the Health Canada before taking the next step forward.

Green Canvas facility is currently undergoing renovations and security upgrades. $50,000 was recently spent on the perimeter fencing alone to be compliant with the stringent Health Canada security guidelines. New cement floors were recently poured for the lab and security storage area. Quotes are now being received for the buildup phase one construction for the production rooms.

GTA Facility

In May 2014, Enertopia signed the definitive joint venture agreement with Lexaria Corp. (CSE: LXX) for the upgrade of a Greater Toronto Area-based facility. Enertopia would own a 51% interest in the production facility, and pay 45% of the ongoing costs in addition to receiving a one-time payment of 500,000 shares of restricted Lexaria stock. The 30,000 square foot facility also has a right of first refusal on an additional 45,000 square feet.

Currently, the facility is awaiting municipal approval for a facility build-out that management expects will take approximately three months. In the meantime, the company plans to submit a building permit in July 2014 and seek MMPR approval thereafter in order to become a licensed producer. The sheer size and potential for expansion could make it one of Canada’s top tier growing facilities, if approved.

The GTA facility is being planned out to be the Company’s flagship project in Canada. Building design is in the final stages, this will include state of the art laboratory facility that will be one of the key components in cannabis research going forward for the Company.

World of Marihuana Facility

In January 2014, Enertopia announced a joint venture with an option to earn up to 51% net revenue interest in the World of Marihuana project in British Columbia. This project also already grows under the Medical Marihuana Access Program (“MMAR”) with 2,500 square feet of production. The facility is currently producing five to six popular cannabis strains.

World of Marihuana applied to the MMPR program in October 2013 and is awaiting a Health Canada site visit. If approved, the existing 2,500 square feet could generate $1,100 in gross revenue per square foot per year.

As an existing producer under the MMAR, the project could also be more likely to be approved than many other MMPR applicants starting from scratch. The discount rates on these valuations could therefore be lower than some competitors.

Looking Ahead

Enertopia is unique among aspiring licensed producers under Canada’s MMPR system due to its three distinct projects located across different parts of Canada. If approved, these three projects could start generating in a little over three months from receiving Health Canada licensed approvals. The long-term potential for these projects is even greater given the many opportunities for expansion.

Investors in aspiring MMPR licensed producers, including Creative Edge Nutrition Inc. (OTC: FITX), Medican Enterprises Inc. (OTC: MDCN), or Modern Mobility Aids (OTC: MDRM), may want to also take a look at Enertopia given its diverse focus, previous MMAR statuses, and significant production capacity.

Click Here To Sign Up For Future Email Updates On Enertopia Corp.

http://www.tdmfinancial.com/emailassets/enrt/enrt_landing.php

For more information, see the following resources:

Company Website – http://www.enertopia.com/s/Home.asp
Investor Presentation – http://www.enertopia.com/i/pdf/Enertopia_Presentation_May_2014.pdf
OTC Markets Profile – http://www.otcmarkets.com/stock/ENRT/quote

 

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/

SOURCE: Emerging Growth LLC

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

CannabisFN Weekly: Stocks Tread Water amid Regulatory Gains

Posted by AGORACOM-JC at 2:06 PM on Tuesday, June 17th, 2014

Whitefish, MT / June 17, 2014 / The Marijuana Index(tm) traded roughly even last week, although the sector remains well below its highs achieved earlier this year.

Top gainers included Fusion Pharm Inc. (OTC: FSPM), which rose more than 70% last week driven by technical trading, and Novus Acquisition & Development Corp. (OTC: NDEV), which rose over 13% last week after making some executive appointments. Top losers included Extreme Biodiesel Inc. (OTC: XTRM) and IMD Companies Inc. (OTC: ICBU), which both fell more than 10% last week.

Cannabis regulatory initiatives also continued to pick up steam last week. In the U.S., Colorado announced the largest grant yet to be dedicated to medical marijuana research. Internationally, Mexico’s president indicated that the country may follow the U.S.’s lead when it comes to legalizing cannabis. Change may be happening slowly, but it appears to be headed towards liberalization over the long run.

What’s New?

Capitalize on Canada’s MMPR Rollout with Enertopia – CannabisFN takes a closer look at Enertopia Corp. (OTC: ENRT) and how the company is well positioned to take advantage of Canada’s new MMPR program.

Colorado Embarks on State-Funded MMJ Research – Colorado’s Department of Health will dole out about $9 million in grants over the next five years to study the effects of medical marijuana.

Cannabis Therapy Targets Low-Hanging Fruit – CannabisFN takes a look at Cannabis Therapy (OTC: CTCO) and its plans to leverage its seasoned management to take advantage of opportunities in the cannabis industry.

Mexico May Follow U.S. Lead in Legalization – Mexico’s President Enrique Pena Nieto recently indicated that the U.S. and Mexico couldn’t pursue diverging policies on marijuana legalization.

Intelligent Highway to Beat Q2 Revenue Forecast – Intelligent Highway Solutions Inc. (OTC: IHSI) expects to report a minimum of $450,000 in revenue for the second quarter of 2014, exceeding expectations.

Exclusive Interview Series

In a recent episode of CannabisFN’s Executive Interview Series, Mike Elliott sits down to talk with Enertopia Corp. CEO Robert McAllister about the company’s mission, plans to expand, and upcoming catalysts for shareholders.

Click Here: Watch the Full Interview

In a recent episode of CannabisFN’s Executive Interview Series, Mike Elliott speaks with Cannabis Therapy CEO Soren Moglesvang about the company’s upcoming plans to capitalize on the cannabis industry and some near-term catalysts.

Click Here: Watch the Full Interview

What to Watch This Week

The cannabis sector traded roughly even last week, with some gainers and losers offsetting each other for the most part. Bellwethers like GW Pharmaceuticals plc (NASDAQ: GWPH) rose nearly 8%, however, signaling that institutional investor interest remains high for companies able to capitalize on it. This week, traders should watch for more progress on the regulatory front to drive price action.

Upcoming Events

WeedStock Conference – June 29 to July 1, 2014 – The 1st Annual Cannabis Investor Conference in Denver, Colorado will feature networking events, industry speakers, expert panels, and more.

About CannabisFN

CannabisFN.com is a dedicated financial network covering new, emerging and established companies operating in the burgeoning multi-billion dollar medical marijuana (“MMJ”) and cannabis industries. CannabisFN’s coverage is syndicated on the leading industry specific and mainstream financial websites and social media. To learn more and request a media kit, visit http://www.cannabisfn.com/market-defining-companies-program/.

To subscribe to the CannabisFN newsletter or read additional coverage on cannabis laws and investments, visit http://www.cannabisfn.com.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

SOURCE: Emerging Growth LLC

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

US House of Representatives Votes to Stop Medical Marijuana Raids

Posted by AGORACOM-JC at 11:23 AM on Monday, June 2nd, 2014
Added by Scott Gaudinier on May 31, 2014.
Saved under Congress, Marijuana, Scott Gaudinier, U.S.
Tags: marijuana

marijuana

Medical marijuana, experiencing a huge spark with a recent outcry of public support across the United States, has now spread to members of Congress, as the U.S. House of Representatives votes to stop federal raids on those who use medical marijuana. Last Thursday evening the House passed an amendment that would prevent the Drug Enforcement Administration (DEA) from pursuing individuals and patients in states where medical use of the drug is legal.

Coming as a pleasant surprise to many citizens across the U.S., the House’s decision reached across party lines, with both Democrats and Republicans showing their support of the amendment with their votes. In a 219 to 189 decision the amendment, led by California Democratic Representative Sam Farr and California Republican Dana Rohrabacher, is the first amendment of its kind to succeed in the House of Representatives.

While the amendment was able to pass mainly due to vast support from Democratic members of the House, there was an observable majority of Republican votes cast in support of the said measure. For this to have happened, the amendment had already been previously backed by a group of co-sponsors from the two opposing parties.

The issue faced in the decision to stop medical marijuana raids was the fact that there was a “routine spending bill” which had been already in place. This allowed for federal tax dollars to be awarded to various government agencies, especially the Justice Department. In turn, the Justice Department has continued its raids of medical marijuana facilities in states across the country where medicinal sales are allowed and adhere to legal terms. However, the new amendment recently passed by the House hopes to prevent federal agencies from continuing these raids henceforth.

Director of Federal Policies at the Marijuana Policy Project Dan Riffle stated that Congress and the overall federal government have begun their shift toward “a more sensible policy” regarding pot, facing strong public pressure. He also made the statement that this vote is historically important after years of the government-initiated “war on drugs” during Ronald Reagan’s years in the White House.

While some critics have made their case that the amendment would only increase the misuse of an “addictive drug” and prevent the DEA from spotting illegal street dealers, House Republican Andy Harris stated in response how other drugs that are addictive have not been advertised as having positive medical benefits.

Unlike marijuana, which many health experts agree has improved patients’ general health, legal substances like nicotine and tobacco cause cancer and have not showed any positive medicinal benefits in any instance. As Harris said, “Nobody writes a prescription and says ‘Smoke a couple of cigarettes and cure your epilepsy.’”

As the U.S. House of Representatives votes to stop medical marijuana raids in the future through the passing of this new amendment, it faces other obstacles as it still needs approval from both the Senate and President Barack Obama. Yet many people across the country, including advocates, patients, doctors, average citizens, and an increasing number of politicians, remain steadfast in their hopes of a nearing reality of both the ultimate decriminalization and legalization of marijuana in the U.S.

By Scott Gaudinier

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Enertopia and Lexaria Update LOI with Signed Definitive Joint Venture Agreement

Posted by AGORACOM-JC at 5:00 AM on Thursday, May 29th, 2014

Vancouver, BC—Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce it has signed the definitive Joint Venture agreement as required in the Letter of Intent that was announced with Lexaria Corp on April 10, 2014.

The Definitive Joint Venture agreement was contemplated at the time of signing the initial April 10, 2014 agreement, and governs the procedures and practices by which the marijuana production facility in the Greater Toronto Area will be operated. As previously reported, Enertopia is paying 45% of costs in order to earn a 51% interest in the facility. The municipal approval process continues to proceed for this facility, located in the Greater Toronto Area

The Company also announces that 200,000 warrants have been exercised raising $20,000 in net proceeds.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Clark Kent at 1.647.519.2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements.  Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates.  The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.  There is no assurance that Lexaria Corp will conclude any Definitive Agreements. Similarly, there can be no assurance that the Company will be successful in attracting key people.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Toronto’s First Financial Investment Conference focused on Medical Marijuana, Industrial Hemp and Alternative Medicine Industries – June 26, 2014

Posted by AGORACOM-JC at 12:35 PM on Friday, May 23rd, 2014

YOU ARE INVITED TO ATTEND

Toronto GreenRush Financial Conference

WHEN June 26, 2014 7:30 a.m. – 6:00 p.m.
WHERE Metro Toronto Convention Centre, Level 100 Constitution Hall
TICKETS Register Online

The conference will feature insightful speakers from a diverse cross section within the above mentioned sectors including government, public and private companies, fund managers, bankers, brokers, investors, lawyers, accountants, analysts, and media representing all aspects of these industries we represent.

VISION: To be the Premier Purveyor of Investment Conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries.

MISSION: To provide a platform/hub to facilitate investment, education and business to business opportunities across the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

GreenRush Financial Conferences is 100% owned by Next Gen Metals Inc. (Next Gen, CSE:N)

After an extremely successful Vancouver conference, May 7, 2014, GreenRush Financial Conferences will be in Toronto on June 26, 2014.

FUTURE CONFERENCES:
CANADA, UNITED STATES AND EUROPE (TO BE ANNOUNCED)

Interested parties or companies wishing to attend the conference can register online by visiting www.greenrushfinancialconferences.com by phone 604.685.1870 Toll Free 1.800.667.1870
For further information on GreenRush Financial Conferences and to book a trade booth, please contact the following people listed below:
Taylor Duncan-Barr [email protected] 604 648.1405
Ray Rich [email protected] 604 648.1401
Ray Lagace [email protected] 604.648.1413

Recent Articles – Interviewskkjksd

About Next Gen Metals Inc., a diversified public company focused on providing financial solutions for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries.(CSE: N, OTC Pink: NXTTF, FSE: M5BN)
  • VISION: To be a Leading provider of venture capital, management expertise, education and a facilitator for this explosive new industry
  • MISSION: To Provide Financial Solutions for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries. Recent regulatory and legal changes in North America have aided Next Gen in accomplishing its mission in these emerging multi-billion dollar industries
  • NEXT GEN’S BUSINESS MODEL: Generates new industry business proposals and plans on a continuous basis. To that end, Management is currently negotiating with a number of companies who are interested in entering into contractual arrangement to co-venture, co-finance, and option-joint venture on one or more of Next Gen’s large inventory of business opportunities and existing 100% owned companies and projects in these multi-billion dollar industry.

GreenRush Analytical Laboratories (GAL)
A wholly owned Subsidiary of Next Gen

  • VISION: To become a leading Laboratory company focused on servicing the legalized cannabis industry in North America.
  • MISSION: To provide analytical testing for the Legal Cannabis Industry in North America by delivering customized solutions and accurate analytical results to our clients.

Recently proposed Canadian Medical Marijuana and Industrial Hemp laws and regulations are anticipated to set additional standards for licensed producers that require more detailed Quality control and Quality assurances from Licensed Producers. GAL is organizing a team of scientists and laboratory technicians to staff our first laboratory. Simultaneously GAL’s management continues to meet with targeted under-funded Analytical Laboratory opportunities for possible mergers and acquisitions.

Management is currently in the process of assessing and selecting initial locations and jurisdictions to establish the laboratories. Management’s objective is to initiate analytical laboratories in areas with the greatest concentration of Licensed Producers in both the legal Medical Marijuana and Industrial Hemp industries.


Next Gen is evaluating multiple new business plans and industry related proposals on an ongoing basis. Management continues to receive and review numerous proposals including: alternative medicine, health, food, agri-business, legal grow-ops, science and technology, client generation, education, public awareness, specialty clinics and ancillary business opportunities. The directors of Next Gen have given management the directive to identify core business opportunities and then to invest in a basket of companies within these emerging sectors.

Toddler’s seizures stopped after consuming cannabis oil, parents say

Posted by AGORACOM-JC at 10:50 AM on Thursday, May 22nd, 2014

JUSTIN GIOVANNETTI

VANCOUVER — The Globe and Mail

Last updated Tuesday, May. 20 2014, 8:05 PM EDT

Two-year-old Kyla Williams hasn‘t learned to walk or talk, her development has stopped as she suffered as many as 200 seizures daily and no medication helped. Now the girl’s family say she hasn’t had a seizure in a week, ever since they began giving her cannabis oil extracted from hemp. (handout from family)

Two-year-old Kyla Williams hasn’t learned to walk or talk, her development has stopped as she suffered as many as 200 seizures daily and no medication helped. Now the girl’s family says she hasn’t had a seizure in a week, ever since they began giving her cannabis oil extracted from hemp.

The oil being used by the toddler has high amounts of cannabidiol, known as CBD, the main ingredient in medical marijuana, and almost no psychoactive ingredients. Its use is in a legal “grey area,” according to proponents.

Only dried marijuana is currently regulated by Health Canada, the sale of resin and oil by growers is forbidden. The hemp that the cannabis oil is being extracted from is supposed to be destroyed by farmers under federal regulations. However, few controls seem to govern the dispensary and parents providing the two-year-old with the oil.

Despite the lack of legal clarity, Kyla is continuing to use her unconventional medicine. On Sunday evening, she had been seizure-free for a week.

“Within 20 minutes of administering it the first time, she stopped her seizures completely. She had six seizures earlier as I said goodbye to her, it was so hard to watch,” said grandmother Elaine Nuessler.

On Saturday, the girl’s grandfather spoke publicly about the need for greater access to the medical marijuana-like substance. A former RCMP officer, Chris Nuessler told a crowd of 60 in Summerland, B.C. that his views on marijuana have changed significantly since his granddaughter began showing signs of uncontrollable epilepsy when she was six months old.

“We come from a background where we’ve never dealt with marijuana before in our lives,” said Ms. Nuessler. “We’ve discovered that it’s a healing plant.”

For more than a year, Kyla was treated with a battery of prescription drugs, none worked, many made her condition worse. Due to the epilepsy, the girl also suffers from serious visual impairments.

After being told by physicians that the girl’s life would be cut short by the seizures, the family contacted Jim Leslie at the Nation’s Best Weeds Society, a dispensary in Vancouver’s east end. Aided by anecdotal evidence that cannabis with high levels of CBD was being used successfully in the United States, Mr. Leslie set out to find something similar in Canada.

He soon came across an often discarded piece of hemp that is high in CBD. “We’ve got a winner here,” he remembers thinking when he saw the results of tests on the plant. “A small, small percentage of farmers are diverting the CBD-rich part of the plants to us,” said Mr. Leslie.

The Vancouver-based dispensary has a note from Kyla’s pediatric physician recommending cannabis. Under federal rules, the family should be providing the two-year-old with medical marijuana in it’s more traditional form.

In the past, Canadians have moved to the U.S. to gain access to the oil. In late 2013, the parents of 13-month-old Kaitlyn Pogson moved to Colorado to obtain the drug, hoping it would help with their daughter’s severe seizures.

With no medical trials showing that cannabis helps children with seizures, Arthur Schafer warned that the impact of the drug’s exposure on a child’s brain remains unknown.

“The rigorous scientific evidence isn’t there, but the anecdotal evidence seems quite promising. Would a reasonable and loving parent take the risk of giving their child medication that could cause serious harm? Not unless the situation is desperate and nothing else has worked,” said Mr. Schafer, the director of the Centre for Professional and Applied Ethics at the University of Manitoba.

“If the harm is there in front of you daily in seizures, the reasonable and loving parent might take the risk. I would.”

Follow Justin Giovannetti on Twitter: @justincgio

Source: http://m.theglobeandmail.com/news/british-columbia/toddlers-seizures-stopped-after-consuming-cannabis-oil-parents-say/article18769814/?service=mobile&cmpid=rss1&click=sf_globe

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Pot Firms Gain as CVS, Walgreen Competition a Pipe Dream

Posted by AGORACOM-JC at 2:13 PM on Tuesday, May 13th, 2014
By Shannon Pettypiece and Sonali Basak May 13, 2014 12:01 AM ET

Photographer: Kathryn Scott Osler/The Denver Post via Getty Images

Kayvan Khalatbari, has poured $500,000 into pot production and $150,000 into a store, started in the industry by delivering medical marijuana door to door. This year, he expects sales of almost $2 million, which may rise to $5 million once he can also begin selling the drug commercially under Colorado law.

Americans seeking medical marijuana for anything from pain to seizures must turn to a patchwork of small startups for help as U.S. laws keep traditional pharmacies out of a market that may exceed $6 billion by 2019.

While more than 21 states have legalized pot for medicinal use, the drug remains illegal under federal law and banks are hesitant to accept money from its sale. That’s keeping drugstore chains CVS Caremark Corp. (CVS), Walgreen Co. and Rite Aid Corp. (RAD), out of the market, leaving local entrepreneurs in control.

“We aren’t going to see a big guy enter this market within the next few years,” said David Yang, an analyst with research firm IBISWorld. “There are just too many regulations and too many elements that make this impossible for them.”

In one state alone, Colorado, more than 400 companies are licensed as medical marijuana centers, with government officials predicting sales there could soon reach $1 billion. For Colorado businessman Kayvan Khalatbari, a former electrical engineer who started his business with just $4,000, federal limitations on the drug are a major benefit.

Khalatbari, who has poured $500,000 into pot production and $150,000 into a store, started in the industry by delivering medical marijuana door to door. This year, he expects sales of almost $2 million, which may rise to $5 million once he can also begin selling the drug commercially under Colorado law, he said.

“We’re making money, we’re employing people, we’re being a beacon of light for this industry and showing it can be done professionally,” Khalatbari said in a telephone interview. “That to me is a success.”

Federal Law

Traditional pharmacies, meanwhile, face a hurdle that keeps them from competing with entrepreneurs like Khalatbari. Even though almost half of states and the District of Columbia accept the drug’s use for medical purposes, marijuana isn’t deemed legal by the federal government. The drug is classified as a Schedule I controlled substance, defined as having a high potential for abuse with no accepted medical use.

The Legalization of Marijuana

Schedule 1 drugs, which includes heroin, can’t by law be prescribed or dispensed. Pharmacies must register with the U.S. Drug Enforcement Agency to dispense controlled substances, making it illegal for them to sell medical marijuana.

Walgreen, Rite Aid and CVS said in separate statements they have no plans to sell medical marijuana. Doing so, according to CVS spokeswoman Carolyn Castel, would violate the company’s registration with the DEA.

Tax Revenue

That may change if the U.S. Congress sees taxes on the drug as a way to raise money, said Brad Barker, an analyst with Bloomberg Industries in New York.

“The second this is legalized they will start rolling out the marijuana cigarettes the next day,” Barker said. “I think the same thing can be said with everything else. Then you’ll have all the big boys jumping into this space.”

More pharmacies would sell medical marijuana if drug companies created cannabis products that can be approved by federal regulators, like drugs or tobacco products, said Mark Kleiman, a professor of public policy at the University of California at Los Angeles School of Public Affairs.

“It’s not drug stores that have to make these decisions, its pharmaceutical companies that have to decide if they want to make cannabis products,” Kleiman said in a telephone interview. Eventually, that could fuel a “big threat to the medical dispensary business model.”

Existing Products

Existing pharmaceutical cannabis products include Marinol, a prescription pill made with synthetic cannabinoid for uses including treating nausea associated by chemotherapy, sold by AbbVie Inc. (ABBV), and Sativex, a spray form of marijuana produced by GW Pharmaceuticals Plc (GWP), a U.K.-based medical marijuana research and development company. Sativex isn’t available in the U.S.

Shareholders are already investing in publicly traded marijuana companies like GW Pharmaceuticals and Advanced Cannabis Solutions Inc. (CANN), a company that leases growing facilities to licensed growers and dispensaries. Barker said he’s tracking 160 public marijuana companies.

American depositary receipts for GW Pharmaceuticals have increased more than sevenfold in the past 12 months to $69.77, raising the company’s market capitalization to $1.24 billion. Shares of Colorado Springs, Colorado-based Advanced Cannabis Solutions, with a market value of about $210 million, has risen more than ninefold to $15.75.

New Investors

Next Gen Metals Inc. (N), a mineral exploration company, is among the investors preparing to put private capital into marijuana startups.

“You can certainly believe the large industries, the large pharmaceutical companies, that they’re looking into it,” Jay Oness, Next Gen’s chief operating officer, said. “When the time is right, I’m positive they’ll want to be a part of it either through acquisitions or by themselves.”

Until legalization or more products are marketed by pharmaceutical companies, it will be an industry dominated by small dispensaries set up to serve about 1.4 million medical marijuana cardholders using the drug to treat their symptoms.

Three states allow medical marijuana companies to make a profit from the sale of pot. The remaining 18 states that approve of the use of medical marijuana require distribution only by nonprofit organizations and cooperatives, according to the Marijuana Policy Project.

To contact the reporters on this story: Shannon Pettypiece in New York at [email protected]; Sonali Basak in New York at [email protected]

To contact the editors responsible for this story: Reg Gale at [email protected] Andrew Pollack

Source: http://www.bloomberg.com/news/2014-05-13/pot-firms-gain-as-cvs-walgreen-competition-a-pipe-dream.html

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks